(Q53223639)

English

A phase II study of weekly paclitaxel/estramustine/carboplatin in hormone-refractory prostate cancer.

scientific article published in September 2006

In more languages
default for all languages
No label defined

No description defined

Statements

A phase II study of weekly paclitaxel/estramustine/carboplatin in hormone-refractory prostate cancer. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit